Asensus Surgical Inc (ASXC)

[DFH84]

My understanding of the conference call was that they had to make a decision to re-submit surgibot for approval, or submit Alf-X for FDA approval, because they cant afford to do both.

It should be clear by now that Alf-X is dead in the water, and has been from day one. It is only slightly less expensive than da vinci, its larger, its based on old technology, and they can't provide the same level of support for it that intuitive surgical can for the da vinci. Therefore it will never EVER take off.

At least the surgibot had the benefit of a low price point to entice smaller medical centers with lower budgets. It will never be a direct competitor to the da vinci, but at the very least it may have been able to carve out a little niche for itself as the best option for healthcare on a budget.

No matter which way you cut it, this company is in deep, deep trouble. My personal opinion however is that pursuing the approval of the Surgibot, and letting Alf-X die is the better of two terrible options.